Invitae Corp (NVTA) News Headlines

▮ More

Date

Headline

7/24/2019 7:30:00 AM Invitae Launches Detect Programs to Make it Easier for Patients to Get Genetic Testing for Prostate Cancer, Muscular Dystrophy and Heart Conditions (Press Release)

6/17/2019 7:35:26 AM Invitae To Buy Singular Bio; Acquisition To Close In The Coming Weeks; Transaction Will Be Cash Neutral At Close

6/17/2019 7:30:00 AM Invitae to Acquire Singular Bio to Help Increase Access to Genetic Screening in Early Pregnancy (Press Release)

6/12/2019 7:33:18 AM Invitae Announces Launch Of ID YOUR IRD Initiative

3/6/2019 9:35:38 PM Invitae Announces Exercise In Full Of Underwriters' Option To Purchase Additional Shares Of Common Stock

3/6/2019 2:13:31 AM BIOL On Watch, CELG Faces FDA In Sep., Scott Gottlieb Resigns

3/5/2019 8:37:26 PM Invitae Prices Underwritten Public Offering Of 9 Mln Shares At $19.00/shr

3/4/2019 4:10:25 PM Invitae Announces Proposed Public Offering Of Common Stock

2/20/2019 8:31:56 PM 8 Top Gainers In Healthcare Sector (LMAT, CLSD, LNTH...)

2/20/2019 12:13:18 AM FDA Nod For NVO's Hemophilia A Drug, ICPT's NASH Trial Hits Goal, NVTA Abuzz

2/19/2019 4:09:14 PM Invitae Q4 Loss/share $0.40 Vs. Loss $0.78 Year Ago

10/29/2018 7:32:59 AM Invitae Corp Expands Partnership With Alnylam Pharma To Provide Access To Genetic Testing For Primary Hyperoxaluria

9/19/2018 10:58:47 PM UBX To Report Phase I Data In Q1, NVTA On Watch, NTGN Faces Busy Year Ahead

9/11/2018 8:09:49 AM Invitae Appoints Chitra Nayak To Its Board

5/10/2018 1:18:00 AM FDA Snubs LPCN Again, NVTA Boosts Revenue Outlook, New Lease Of Life For VTVT

3/28/2018 6:32:42 AM Invitae Corp. (NVTA) Sank On Offering News

3/28/2018 6:01:58 AM Invitae Prices Underwritten Public Offering Of 11.1 Mln Shares At $4.50/shr

3/27/2018 9:41:50 AM Invitae Corp. (NVTA) Is Losing Ground After Offering Announcement

3/26/2018 4:06:27 PM Invitae Announces Proposed Public Offering Of Common Stock

2/12/2018 4:09:05 PM EARNINGS SUMMARY: Details of Invitae Corp Q4 Earnings Report